Merlin's shopping spree

Merlin Biosciences is wasting no time in rounding out the portfolio for its EUR 247 million ($212.4 million) fund, which closed in September. Merlin announced three new investments last week, bringing the number of companies in

Read the full 362 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE